Cancer Drug Costs Could Skyrocket Under Obamacare

Cancer Drug Costs Could Skyrocket Under Obamacare 2014-12-29T15:59:54-07:00

 

Containing health care costs is a little bit like trying to stuff an elephant into an old-fashioned telephone booth.

You push one part in, and another part comes busting back out.

The Affordable Health Care Act was supposed to control health care costs and make health coverage available to all Americans. It was also supposed to provide conscience exemptions and to not fund abortions.

So far, things are working out too well.

The HHS Mandate, which is a government regulation designed to implement the Affordable Health Care Act puts the promises of protecting conscience to the lie. Massive block grants for “sex education,” i.e., indoctrination in sexual disorders, to Planned Parenthood put the promises about not funding abortion to the lie.

We’re down to the “affordable” part of the Affordable Health Care Act, and it’s not looking so good, either. 

The main problem, (surprise!) is profiteering by drug companies and how elected officials in the various states respond to this.

Let me give you a hint: If the drug companies can buy the FDA and the United States Congress, do you seriously think they can’t also buy the various state legislatures?

If other legislatures are like the one here in Oklahoma, all they really need to flat-out buy is three people: The Speaker of the House, the Pro Tempore of the Senate and the Governor. They can then spread a little money around (in the form of legal campaign donations and dinners) to all the munchkin/puppet legislators sitting behind desks on the floor and the deal is done and done.

They win. The people — or at least those who get cancer — are bankrupt.

Oklahoma is a state where the House leadership adjourned the legislative session for several days a couple of years ago, so the leadership and a few hand-picked legislators could go on a junket. Rumor has it that the Senate has done the same thing not so very long ago.

So …. you fill in the dots about where the people stand in all this.

The Affordable Health Care Act may not turn out to be all that affordable for little guys who are trying to chug a serious illness. It has already proven to be a dreadnought that is blasting away at freedom of conscience with the full force of the federal government. As for not funding abortions, if Planned Parenthood was speaking candidly, all they would say is, ka-ching, ka-ching.

From the Associated Press:

WASHINGTON (AP) — Cancer patients could face high costs for medications under President Barack Obama’s health care law, industry analysts and advocates warn. 
Where you live could make a huge difference in what you’ll pay. 
To try to keep premiums low, some states are allowing insurers to charge patients a hefty share of the cost for expensive medications used to treat cancer, multiple sclerosis, rheumatoid arthritis and other life-altering chronic diseases. 
Such “specialty drugs” can cost thousands of dollars a month, and in California, patients would pay up to 30 percent of the cost. For one widely used cancer drug, Gleevec, the patient could pay more than $2,000 for a month’s supply, says the Leukemia & Lymphoma Society. 
New York is taking a different approach, setting flat dollar copayments for medications. The highest is $70, and it would apply to specialty drugs as well. 
Critics fear most states will follow California’s lead, and that could defeat the purpose of Obama’s overhaul, because some of the sickest patients may be unable to afford their prescriptions. 
“It’s important that the benefit design not discriminate against people with chronic illness, and high copays do that,” said Dan Mendelson, president of Avalere Health, a data analysis firm catering to the health care industry and government. 
Avalere’s research shows that 1 in 4 cancer patients walks away from the pharmacy counter empty-handed when facing a copay of $500 or more for a newly prescribed drug. 
“You have to worry about a world where if you happen to contract cancer or multiple sclerosis, you are stuck with a really big bill,” Mendelson said. “It’s going to be very important for states to take a long, hard look at their benefit design.” 
Although the money for covering uninsured Americans is coming from Washington, the heath care law gives states broad leeway to tailor benefits, and the local approach can also allow disparities to emerge. 
A spokesman for Covered California said state officials are trying to balance between two conflicting priorities: comprehensive coverage and affordable premiums. 
“We are trying to keep the insurance affordable across the board,” said Dana Howard, the group’s spokesman. “This is just part of trying to manage the overall risk of the pool.” Covered California is one of the new state marketplaces where people who don’t get coverage on the job will be able to shop for private insurance starting this fall. Coverage takes effect Jan. 1. 
Insurers are forecasting double-digit premium increases for individual policies, as people with health problems flock to buy coverage previously denied them. The Obama administration says the industry warnings are overblown, and that for many consumers, premium increases will be offset by tax credits to help buy insurance. And officials say it’s important to realize that the law sets overall limits on patients’ liability, even if those seem high to some people. Still, a full picture of costs and benefits isn’t likely to come into focus until the fall. 
Howard said California officials are aware of the concerns about drug costs and are trying to make medications more affordable. 
Meanwhile, he said consumers will be protected because the law limits total out-of-pocket costs — the deductibles and copayments that policy holders are responsible for, apart from monthly premiums. In California, the annual out-of-pocket limit for an individual is $6,400, although it can be as low as $2,250 for low-income people. Once that limit is reached, insurance pays 100 percent. 
That’s still a lot of money, and such reassurances haven’t dispelled the concerns. (Read the rest here.)


Browse Our Archives